SynAct Pharma AB (STO:SYNACT)
Sweden · Delayed Price · Currency is SEK 17.14
-0.08 (-0.46%)
Oct 13, 2026, 11:13 AM CET
SynAct Pharma AB Employees
SynAct Pharma AB had 8 employees as of June 30, 2026. The number of employees increased by 2 or 33.33% compared to the same quarter last year. That makes SynAct Pharma AB the 40,798th largest employer in the world and 671st in Sweden.
Employees
8
Change
2
Growth
33.33%
Revenue / Employee
n/a
Profits / Employee
-13.27M SEK
Market Cap
959.81M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 8 | 2 | 33.33% |
| Mar 31, 2026 | 8 | 2 | 33.33% |
| Dec 31, 2025 | 8 | 2 | 33.33% |
| Sep 30, 2025 | 8 | 3 | 60.00% |
| Jun 30, 2025 | 6 | 1 | 20.00% |
| Mar 31, 2025 | 6 | 1 | 20.00% |
| Dec 31, 2024 | 6 | 1 | 20.00% |
| Sep 30, 2024 | 5 | 0 | - |
| Jun 30, 2024 | 5 | 0 | - |
| Mar 31, 2024 | 5 | 0 | - |
| Dec 31, 2023 | 5 | 0 | - |
| Sep 30, 2023 | 5 | 0 | - |
| Jun 30, 2023 | 5 | 1 | 25.00% |
| Mar 31, 2023 | 5 | 0 | - |
| Dec 31, 2022 | 5 | 2 | 66.67% |
| Sep 30, 2022 | 5 | 2 | 66.67% |
| Jun 30, 2022 | 4 | 1 | 33.33% |
| Mar 31, 2022 | 5 | - | - |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioInvent International AB | 108 |
| Oncopeptides AB | 69 |
| Saniona AB | 44 |
| Genovis AB (publ.) | 42 |
| Xspray Pharma AB | 24 |
| Cantargia AB | 22 |
| AlzeCure Pharma AB | 10 |
| FluoGuide | 7 |
SynAct Pharma AB News
- 20 days ago - SynAct Pharma AB Transcript: Investing in Life Science 2026 - Transcripts
- 5 weeks ago - SynAct Pharma AB Slides: Company presentation - Filings
- 7 weeks ago - SynAct Pharma AB Quarterly report: Q2 2026 - Filings
- 3 months ago - SynAct Pharma AB Slides: Company presentation - Filings
- 4 months ago - SynAct Pharma AB Transcript: Study result - Transcripts
- 4 months ago - SynAct Pharma AB Press release: Study result - Filings
- 4 months ago - SynAct Pharma AB Transcript: Aktiedagarna 2026 - Transcripts
- 4 months ago - SynAct Pharma AB Quarterly report: Q1 2026 - Filings